Products
- 
        
  
    .png)  Rick Doblin on the FDA's MDMA Decision and the Future of Psychedelic TherapyCourseTimely insights from Rick Doblin on the FDA's decision on MDMA and its impact on psychedelic research and therapy in 2025. Free 
- 
        
  
    .png)  Webinar: Cannabis & Psychedelics from Conceptualization to Care in CanadaCourseThis recorded webinar features instructors from the Cannabis and Psychedelics: From Conceptualization to Care in Canada course discussing whether or not cannabis is a psychedelic, why that matters, and to whom. $10 
- 
        
  
      Balancing Safety & Access Webinar Series: Healing Trauma with PsychedelicsCourseDiscover how to balance safety with access in trauma healing. Explore pharmacology, ancestral trauma, and the role of psychedelics in therapeutic practices. Join diverse voices discussing innovative healing methods and their implications. $10 
- 
        
  
      Balancing Safety & Access Webinar Series: Psychedelics for End of Life & Existential distressCourseJoin us for a crucial discussion on providing safe and accessible psychedelic therapy to individuals facing end-of-life or existential distress due to mental health challenges. Hear from experts on the ethical, legal, and social implications. $10 
- 
        
  
    .png)  Balancing Safety & Access Webinar Series: The Impact of Canadian Psychedelics Law on Indigenous Ways of HealingCourse$10 
- 
        
  
      Balancing Safety & Access Webinar Series: Training for Psychedelics-Assisted Care ProvidersCourseEnhance your therapeutic practice with our comprehensive training for psychedelic-assisted care providers. Led by experts, this course offers critical skills, legal guidance, and ethical frameworks essential for integrating psychedelics into therapy $10